Table 2.
Reported pharmacological activities of Solanum nigrum L. useful in COVID-19
| Sr. no | Activity | Plant part | Extract | Conc/Dose | Model | Effect | Reference |
|---|---|---|---|---|---|---|---|
| 1 | Anti-inflammatory | Berries | MeOH | 125, 250 and 375 mg/kg | Carrageenan induced rat paw edema | 23.45% reduction in edema caused by carrageenan after 3 h | [65] |
| 2 | Berries | EtOH | 100–300 mg/kg | Carrageenan induced rat paw edema | 63% inhibition at the highest dose of 300 mg//kg | [66] | |
| 3 | Fruits | EtOH | 125–1000 mg/ml | TPA inflammation induction model using RAW264.7 cells | 79.8% inhibition of NO production | [67] | |
| 4 | Whole plant | MeOH | 100 and 200 mg/kg | Carrageenan induced rat paw edema | 44.81% inhibition in albino rats at the maximum dose | [68] | |
| 5 | Whole plant | EtOH | 100 and 200 mg/kg | Carrageenan induced rat paw edema | 100 and 200 mg/kg exhibited 40.36% and 68.46% inhibition respectively | [69] | |
| 6 | Berries | MeOH | 2.5, 5, 10, 20, 40, 50 µM | LPS-induced model | IC50 11.33 to 49.35 mM | [70] | |
| 7 | Antiviral Activity | Whole plant | MeOH | 100 μg/μl | Huh-7 cell lines | Methanolic extract of S. nigrum shows 37% inhibition | [37] |
| Seeds | Chloroform | Chloroform extract shows 50% inhibition of HCV | |||||
| 8 | Aerial parts | Aqueous | 100 μg/μl | Human T-cell line | 32.6% inhibition in HIV-PR | [36] | |
| 17.4% inhibition against HIV-1 RT | |||||||
| 9 | Immunomodulation | Whole plant | EtOH | 90, 180, and 360 mg/kg | ELISA Method: IFN-α and IL-4 assay | Significant increase in the CD4+ and decrease in the percentage of CD8+ T lymphocyte | [71] |
| 10 | Whole plant | Aqueous | 50, 100, and 200 mg/kg | H22 cell lines | IL-2 and IFN-γ levels increased significantly in H22 bearing mice | [72] | |
| 11 | Dried stems | Aqueous | 200 μg/ml | ELISA, Flow cytometry |
Increase in the CD4+/CD8+ lymphocyte ratio as well as the immune organ indexes |
[73] |
MeOH Methanol, EtOH Ethanol